as 08-22-2025 4:00pm EST
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Founded: | 2011 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 1.2B | IPO Year: | 2025 |
Target Price: | $25.00 | AVG Volume (30 days): | 430.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.81 | EPS Growth: | N/A |
52 Week Low/High: | $14.14 - $28.40 | Next Earning Date: | 08-07-2025 |
Revenue: | $209,827,000 | Revenue Growth: | 135.27% |
Revenue Growth (this year): | 33.26% | Revenue Growth (next year): | 20.16% |
OMDA Breaking Stock News: Dive into OMDA Ticker-Specific Updates for Smart Investing
TipRanks
2 months ago
GlobeNewswire
2 months ago
Bloomberg
2 months ago
Bloomberg
3 months ago
Yahoo Finance Video
3 months ago
Yahoo Finance
3 months ago
Yahoo Finance Video
3 months ago
The information presented on this page, "OMDA Omada Health Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.